RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA

Conditions: Obstructive Sleep Apnea Interventions: Drug: IHL-42X Low Dose; Drug: IHL-42X High Dose; Drug: Placebo; Drug: IHL-42X (Optimal Dose); Drug: Dronabinol; Drug: Acetazolamide; Drug: Placebo Sponsors: Incannex Healthcare Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials